DalsnaFinance

Alamar Biosciences $ALMR

Health Care

Russell 2000 California
Create a scorecard
$37.76
+3.40 (+9.90%)
As of Oct 5, 2026, 3:41 PM EDT · cached
Price history
Loading chart…

Alamar Biosciences (ALMR) is trading up at $37.76 (+9.90%), as of the latest quote. It is a Russell 2000 constituent in the Health Care sector.

IPO: April 17, 2026 · $17.00 offering · NASDAQ · View IPO details →

Alamar Biosciences revenue & net income history

RevenueNet income
$29.4M$4.05M−$21.3MQ1 FY2025 revenue: $13.1MQ1 FY2025 net income: −$7.66MQ1 '25Q2 FY2025 revenue: $16.2MQ2 FY2025 net income: −$7.02MQ2 '25Q1 FY2026 revenue: $26.0MQ1 FY2026 net income: −$21.3MQ1 '26Q2 FY2026 revenue: $29.4MQ2 FY2026 net income: −$13.2MQ2 '26
Alamar Biosciences quarterly financial statements
Q1 FY25Mar 2025Q2 FY25Jun 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Income statement
Revenue$13.1M$16.2M$26.0M$29.4M
Growth (year over year)——+98.9%+82.1%
Gross profit$6.39M$8.58M$14.5M$17.7M
Gross margin48.8%53.1%55.5%60.2%
Operating income−$8.55M−$7.92M−$12.3M−$13.5M
Operating margin−65.3%−49.0%−47.4%−46.0%
Net income−$7.66M−$7.02M−$21.3M−$13.2M
Net margin−58.5%−43.5%−81.9%−44.9%
EPS (diluted)−$0.68−$0.62−$1.74−$0.22
Balance sheet
Cash and equivalents——$64.6M$133.0M
Total assets——$186.5M$391.0M
Total liabilities——$129.5M$78.1M
Shareholders' equity−$140.3M−$146.6M−$178.1M$312.9M
Cash flow
Operating cash flow−$13.1M−$11.9M−$20.3M−$11.3M
Capital expenditure$554.0K$753.0K$600.0K$3.64M
Free cash flow−$13.6M−$12.6M−$20.9M−$15.0M

From Alamar Biosciences's 10-Q filings with the SEC. Each period shows the latest figure the company has reported for it, including restatements. Filings on SEC EDGAR →

About Alamar Biosciences

Headquarters
Fremont, California From SEC filings, Oct 2026

Recent News (2)

More Health Care stocks

Browse all companies →